Pacer BioThreat Strategy ETF News
Biotech Looks Past Its Latest <I>Annus Horribilis</I>
A long line of applications, a new FDA commissioner and lower values may kick-start the sector.
Gilead to Acquire Triangle Pharmaceuticals
The $464 million cash deal will combine two companies that specialize in HIV treatments.
Biotechs Tune Up for the Mating Dance
Flush with cash and eager for new products, some companies may get the urge to merge.
Breaking News
Elon Musk Throws Dogecoin a Lifeline
Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.